Siew C. Ng, Hai Yun Shi, Nima Hamidi, Fox E. Underwood, Whitney Tang: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. In: The Lancet. Band390, Nr.10114, Dezember 2017, S.2769–2778, doi:10.1016/S0140-6736(17)32448-0.
Mark S. Silverberg et al.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. In: Canadian Journal of Gastroenterology. 19 Suppl A, September 2005, S.5A–36A, doi:10.1155/2005/269076, PMID 16151544 (englisch).
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young, Michael O. Blackstone: Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. In: Gastrointestinal Endoscopy. Band56, Nr.1, Juli 2002, ISSN0016-5107, S.48–54, doi:10.1067/mge.2002.125367, PMID 12085034.
R. J. Xavier, D. K. Podolsky: Unravelling the pathogenesis of inflammatory bowel disease. In: Nature. Band448, Nr.7152, 26. Juli 2007, S.427–434, doi:10.1038/nature06005, PMID 17653185 (englisch).
K. Dahm, A. Knipper, H. Mitschke: Maligne Entartung der Colitis ulcerosa im Experiment. In: Langenbecks Archiv für Chirurgie. Band343, Nr.4, 1. Dezember 1976, ISSN1435-2451, S.307–311, doi:10.1007/BF01300577.
M. S. Sajadinejad, K. Asgari, K. Molavi, M. Kalantari, P. Adibi: Psychological issues in inflammatory bowel disease: an overview. In: Gastroenterology research and practice. 2012; doi:10.1155/2012/106502, PMID 22778720.
Hafiz M Waqas Khan, Faisal Mehmood, Nabeel Khan: Optimal management of steroid-dependent ulcerative colitis. In: Clinical and Experimental Gastroenterology. Band8, 12. November 2015, ISSN1178-7023, S.293–302, doi:10.2147/CEG.S57248, PMID 26648749, PMC 4648600 (freier Volltext).
John K. Marshall, Marroon Thabane, A. Hillary Steinhart, Jamie R. Newman, Anju Anand: Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. In: Cochrane Database of Systematic Reviews. 20. Januar 2010, doi:10.1002/14651858.CD004115.pub2.
Yongjun Wang, Claire E. Parker, Brian G. Feagan, John K. MacDonald: Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. In: Cochrane Database of Systematic Reviews. 9. Mai 2016, doi:10.1002/14651858.CD000544.pub4, PMID 27158764, PMC 7045447 (freier Volltext).
Fernando S. Velayos, Jonathan P. Terdiman, Judith M. Walsh: Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies. In: The American Journal of Gastroenterology. Band100, Nr.6, Juni 2005, ISSN0002-9270, S.1345–1353, doi:10.1111/j.1572-0241.2005.41442.x.
William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert R. D’Haens, Séverine Vermeire: Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. In: New England Journal of Medicine. Band376, Nr.18, 4. Mai 2017, ISSN0028-4793, S.1723–1736, doi:10.1056/NEJMoa1606910.
C. Vissiennon et al.: Antispasmodic Effects of Myrrh due to Calcium Antagonistic Effects in Inflamed Rat Small Intestinal Preparations. In: Planta Med, 2015 Jan;81(2):116–122, doi:10.1055/s-0034-1383391.
Rita Rosenthal et al.: Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells. In: International Journal of Colorectal Disease. Band 32, 2017, S 623–634. (doi:10.1007/s00384-016-2736-x)
Laura Weber et al.: Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa. Biomolecules. 2020 Jul; 10(7): 1033. (doi:10.3390/biom10071033)
BM Calkins: A meta-analysis of the role of smoking in inflammatory bowel disease. In: Digestive Diseases and Sciences. 34. Jahrgang, Nr.12, 1989, S.1841–1854, doi:10.1007/BF01536701, PMID 2598752.
PL Lakatos, T Szamosi, L Lakatos: Smoking in inflammatory bowel diseases: good, bad or ugly? In: World Journal of Gastroenterology. 13. Jahrgang, Nr.46, 2007, S.6134–6139, doi:10.3748/wjg.13.6134, PMID 18069751, PMC 4171221 (freier Volltext).
Mark S. Silverberg et al.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. In: Canadian Journal of Gastroenterology. 19 Suppl A, September 2005, S.5A–36A, doi:10.1155/2005/269076, PMID 16151544 (englisch).
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young, Michael O. Blackstone: Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. In: Gastrointestinal Endoscopy. Band56, Nr.1, Juli 2002, ISSN0016-5107, S.48–54, doi:10.1067/mge.2002.125367, PMID 12085034.
R. J. Xavier, D. K. Podolsky: Unravelling the pathogenesis of inflammatory bowel disease. In: Nature. Band448, Nr.7152, 26. Juli 2007, S.427–434, doi:10.1038/nature06005, PMID 17653185 (englisch).
K. Kemp, J. Griffiths, K. Lovell: Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence. In: World journal of gastroenterology. 2012; 18 (43), S. 6240–6249, PMID 23180944.
L. A. Graff, J. R. Walker, L. Lix, I. Clara, P. Rawsthorne, L. Rogala, N. Miller, L. Jakul, C. McPhail, J. Ediger, C. N. Bernstein: The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. In: Clinical gastroenterology and hepatology. 2006; 4 (12), S. 1491–1501, PMID 17162241. L. A. Graff, J. R. Walker, C. N. Bernstein: Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. In: Inflammatory bowel diseases. 2009; 15 (7), S. 1105–1118, PMID 19161177.
M. S. Sajadinejad, K. Asgari, K. Molavi, M. Kalantari, P. Adibi: Psychological issues in inflammatory bowel disease: an overview. In: Gastroenterology research and practice. 2012; doi:10.1155/2012/106502, PMID 22778720.
Hafiz M Waqas Khan, Faisal Mehmood, Nabeel Khan: Optimal management of steroid-dependent ulcerative colitis. In: Clinical and Experimental Gastroenterology. Band8, 12. November 2015, ISSN1178-7023, S.293–302, doi:10.2147/CEG.S57248, PMID 26648749, PMC 4648600 (freier Volltext).
Yongjun Wang, Claire E. Parker, Brian G. Feagan, John K. MacDonald: Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. In: Cochrane Database of Systematic Reviews. 9. Mai 2016, doi:10.1002/14651858.CD000544.pub4, PMID 27158764, PMC 7045447 (freier Volltext).
BM Calkins: A meta-analysis of the role of smoking in inflammatory bowel disease. In: Digestive Diseases and Sciences. 34. Jahrgang, Nr.12, 1989, S.1841–1854, doi:10.1007/BF01536701, PMID 2598752.
PL Lakatos, T Szamosi, L Lakatos: Smoking in inflammatory bowel diseases: good, bad or ugly? In: World Journal of Gastroenterology. 13. Jahrgang, Nr.46, 2007, S.6134–6139, doi:10.3748/wjg.13.6134, PMID 18069751, PMC 4171221 (freier Volltext).
A. Hueppe, J. Langbrandtner, H. Raspe: Inviting patients with inflammatory bowel disease to active involvement in their own care: a randomized controlled trial. In: Inflammatory bowel diseases. 2014; 20 (6), S. 1057–1069, PMID 24788217.
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young, Michael O. Blackstone: Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. In: Gastrointestinal Endoscopy. Band56, Nr.1, Juli 2002, ISSN0016-5107, S.48–54, doi:10.1067/mge.2002.125367, PMID 12085034.
K. Dahm, A. Knipper, H. Mitschke: Maligne Entartung der Colitis ulcerosa im Experiment. In: Langenbecks Archiv für Chirurgie. Band343, Nr.4, 1. Dezember 1976, ISSN1435-2451, S.307–311, doi:10.1007/BF01300577.
Hafiz M Waqas Khan, Faisal Mehmood, Nabeel Khan: Optimal management of steroid-dependent ulcerative colitis. In: Clinical and Experimental Gastroenterology. Band8, 12. November 2015, ISSN1178-7023, S.293–302, doi:10.2147/CEG.S57248, PMID 26648749, PMC 4648600 (freier Volltext).
Fernando S. Velayos, Jonathan P. Terdiman, Judith M. Walsh: Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies. In: The American Journal of Gastroenterology. Band100, Nr.6, Juni 2005, ISSN0002-9270, S.1345–1353, doi:10.1111/j.1572-0241.2005.41442.x.
William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert R. D’Haens, Séverine Vermeire: Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. In: New England Journal of Medicine. Band376, Nr.18, 4. Mai 2017, ISSN0028-4793, S.1723–1736, doi:10.1056/NEJMoa1606910.